Zentek (ZEN) Stock Price, News & Analysis

Company Overview

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Key Stats

• Today's Range: C$1.25 to C$1.45
• 50-Day Range: C$1.31 to C$1.69
• 52-Week Range: C$0.75 to C$1.82
• Volume: 35,160 shs
• Average Volume: 33,386 shs
• Market Capitalization: C$134.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ZEN Stock Analysis - Frequently Asked Questions

How have ZEN shares performed this year?

Zentek's stock was trading at C$1.32 at the beginning of the year. Since then, ZEN stock has decreased by 0.8% and is now trading at C$1.31.
View the best growth stocks for 2025 here.

How do I buy shares of Zentek?

Shares of ZEN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Zentek own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Zentek investors own include ZEN Graphene Solutions (ZENYF), Bird Construction (BDT), Norbord (OSB), Stuart Olson (SOX), ARC Resources (ARX), Corus Entertainment (CJR) and Parex Resources (PXT).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: CVE:ZEN
• CIK: N/A
• Web: www.zentek.com
• Phone: +1-807-3461660
• Fax: N/A
• Employees: 24
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-10,747,265.22
• Net Margins: -27,291.69%
• Pretax Margin: N/A
• Return on Equity: -54.00%
• Return on Assets: -27.09%

Debt

• Debt-to-Equity Ratio: 4.97
• Current Ratio: 2.06
• Quick Ratio: 7.59

Sales & Book Value

• Annual Sales: C$39,379.26
• Price / Sales: 3,417.47
• Cash Flow: C$0.09 per share
• Price / Cash Flow: 13.85
• Book Value: C$0.18 per share
• Price / Book: 7.24

Miscellaneous

• Outstanding Shares: 102,730,833
• Free Float: N/A
• Market Cap: C$134.58 million
• Optionable: Not Optionable
• Beta: 0.77